Prostamax

Prostamax is a short peptide bioregulator developed from
the research of Professor Vladimir Khavinson and colleagues.
It is derived from natural peptides associated with prostate tissue and
is being studied for its ability to regulate cellular functions,
support prostate health, and maintain normal urogenital function.
Prostamax is primarily investigated in the fields of anti-aging,
urology, and preventive medicine.

1. Prostate Function

Prostamax has been studied for its ability to normalize prostate gland activity
and support healthy cellular function in the prostate.
It may help regulate metabolic processes at the tissue level.

2. Urological Health

Research suggests Prostamax may support bladder and urinary function,
particularly in age-related changes of the prostate gland.

3. Anti-Aging Applications

As part of the Khavinson peptide family, Prostamax has been examined for
its role in slowing age-related degeneration of the prostate,
potentially contributing to overall male longevity and health.

4. Cytoprotective Effects

Studies indicate short peptides like Prostamax may have antioxidant
and protective properties, improving resilience of prostate cells
against stress and damage.

Future studies may explore Prostamax’s role in benign prostatic hyperplasia (BPH),
prostate inflammation, and age-associated urogenital disorders.
Additional research may also examine its potential synergy with other Khavinson peptides
in systemic anti-aging and preventive medicine.